CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Rapamycin decreases proinflammatory and profibrogenic gene expression in experimental NASH
DOI 10.1055/s-0029-1191819
Bibliografische Angaben
Nachweis in CareLit
Autor:innenE Gäbele, K Dostert, C Dorn, G Koehl, EK Geissler, J Schoelmerich, C Hellerbrand
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2009
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Because of the increasing incidence of NASH and obesity in the western world, the use of fatty grafts for patients requiring liver transplantation is an evolving problem. Rapamycin, which has antifibrotic properties, is an immunosuppressant widely used after liver transplantation. Therefore, we hypothesized that rapamycin could attenuate profibrogenic and proinflammatory gene expression in a model of dietary N…
Zitieren
Zitierempfehlung
E Gäbele, K Dostert, C Dorn, G Koehl, EK Geissler, J Schoelmerich, C Hellerbrand (2009) Rapamycin decreases proinflammatory and profibrogenic gene expression in experimental NASH. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0029-1191819
Mit CareLit weiterarbeiten